Atosiban CAS:90779-69-4

Atosiban, sold under the brand name Tractocile among others, is an inhibitor of the hormones oxytocin and vasopressin. Používa sa ako intravenózny liek na potlačenie pôrodu (tokolytický) zastaviť predčasný pôrod. It was developed by Ferring Pharmaceuticals in Sweden and first reported in the literature in 1985.Originally marketed by Ferring Pharmaceuticals, it is licensed in proprietary and generic forms for the delay of imminent preterm birth in pregnant adult women.

Atosiban is used to delay birth in adult women who are 24 do 33 weeks pregnant, when they show signs that they may give birth pre-term (prematurely).These signs include regular contractions lasting at least 30 sekundy rýchlosťou aspoň štyri každé 30 minút,a dilatáciu krčka maternice (krčka maternice) z 1 do 3 cm a vymazanie (miera tenkosti krčka maternice) z 50% alebo viac.Okrem toho, dieťa musí mať normálnu srdcovú frekvenciu.